NIH Reporter #11350875

NCI Seeks Research Services Targeting Tumor Heterogeneity in Neuroendocrine Prostate Cancer

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is seeking research services to address tumor heterogeneity in neuroendocrine prostate cancer. - Government Buyer: - National Cancer Institute (NCI), NIH - OEMs and Vendors: - No specific OEMs or commercial vendors are named in this solicitation - Products/Services Requested: - Advanced cancer research services focused on targeting the drivers of tumor heterogeneity to block progression to neuroendocrine prostate cancer - Includes molecular and genetic studies, gene editing, and bioinformatics analysis - Research to be conducted at Weill Medical College of Cornell University, New York, NY - Unique or Notable Requirements: - Emphasis on innovative scientific approaches to develop new therapeutic strategies - No specific equipment, software, or branded products are required - Open to research proposals with a strong scientific focus

Description

This is a research project funded by the NIH/NCI focusing on prostate cancer, specifically targeting tumor heterogeneity to prevent progression to neuroendocrine prostate cancer. The project involves molecular and genetic studies, including gene editing and bioinformatics analysis. The goal is to develop new therapeutic strategies to combat this form of cancer.

View original listing